Publications

A Deep Learning Framework For Clinical Trial Enrichment in Alzheimer’s Disease

The selection of participants at risk of cognitive decline in clinical trials, known as trial enrichment, increases the probability of trial success. It is estimated that by 2050, 153 million people worldwide will be living with a type of dementia. Hence, innovative trial recruitment strategies are necessary to accelerate treatment development.